BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20717027)

  • 1. Are we any closer to beating the biofilm: novel methods of biofilm control.
    Ramage G; Culshaw S; Jones B; Williams C
    Curr Opin Infect Dis; 2010 Dec; 23(6):560-6. PubMed ID: 20717027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilms in dermatology.
    Nusbaum AG; Kirsner RS; Charles CA
    Skin Therapy Lett; 2012 Jul; 17(7):1-5. PubMed ID: 22825648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal biofilms in human disease.
    Williams C; Ramage G
    Adv Exp Med Biol; 2015; 831():11-27. PubMed ID: 25384660
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms.
    Van Acker H; Van Dijck P; Coenye T
    Trends Microbiol; 2014 Jun; 22(6):326-33. PubMed ID: 24598086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial biofilms: biosurfactants as antibiofilm agents.
    Banat IM; De Rienzo MA; Quinn GA
    Appl Microbiol Biotechnol; 2014 Dec; 98(24):9915-29. PubMed ID: 25359476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing.
    Black CE; Costerton JW
    Surg Clin North Am; 2010 Dec; 90(6):1147-60. PubMed ID: 21074033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine activity against bacterial biofilms.
    Bonez PC; Dos Santos Alves CF; Dalmolin TV; Agertt VA; Mizdal CR; Flores Vda C; Marques JB; Santos RC; Anraku de Campos MM
    Am J Infect Control; 2013 Dec; 41(12):e119-22. PubMed ID: 23910527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strength in numbers: antifungal strategies against fungal biofilms.
    Ramage G; Robertson SN; Williams C
    Int J Antimicrob Agents; 2014 Feb; 43(2):114-20. PubMed ID: 24359842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters.
    Liu F; Hansra S; Crockford G; Köster W; Allan BJ; Blondeau JM; Lainesse C; White AP
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.
    Liu Y; Wang L; Zhou X; Hu S; Zhang S; Wu H
    Int J Antimicrob Agents; 2011 Jan; 37(1):33-8. PubMed ID: 20956070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors?
    Cobrado L; Azevedo MM; Silva-Dias A; Ramos JP; Pina-Vaz C; Rodrigues AG
    J Antimicrob Chemother; 2012 May; 67(5):1159-62. PubMed ID: 22316569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches.
    Jorge P; Lourenço A; Pereira MO
    Biofouling; 2012; 28(10):1033-61. PubMed ID: 23016989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating biofilms.
    Yang L; Liu Y; Wu H; Song Z; Høiby N; Molin S; Givskov M
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):146-57. PubMed ID: 22066868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial biofilm communities in the gastrointestinal tract.
    Macfarlane S
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S142-3. PubMed ID: 18806707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
    García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A
    J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the resistance of microbial biofilms: has proteomics been helpful?
    Seneviratne CJ; Wang Y; Jin L; Wong SS; Herath TD; Samaranayake LP
    Proteomics; 2012 Feb; 12(4-5):651-65. PubMed ID: 22246638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm inhibition and antimicrobial action of lipopeptide biosurfactant produced by heavy metal tolerant strain Bacillus cereus NK1.
    Sriram MI; Kalishwaralal K; Deepak V; Gracerosepat R; Srisakthi K; Gurunathan S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):174-81. PubMed ID: 21458961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections.
    Rice SA; McDougald D; Kumar N; Kjelleberg S
    Curr Opin Investig Drugs; 2005 Feb; 6(2):178-84. PubMed ID: 15751741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.